AMD Therapeutics Market Size to Grow by USD 9.37 Bn, Wet AMD to be Largest Revenue-generating Type Segment - Technavio

14 Oct 2022
www.prnewswire.com
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- The age-related macular degeneration (AMD) therapeutics market size is expected to grow by USD 9.37 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 12.6% during the forecast period, according to Technavio. The high prevalence of AMDAMD is driving the age-related macular degeneration (AMD) therapeutics market growth. However, factors such as the lack of approved therapies for dry AMDAMD may challenge the market growth.
Continue Reading
AMD Therapeutics Market Size to Grow by USD 9.37 Bn, Wet AMD to be Largest Revenue-generating Type Segment - Technavio
Preview
Source: PRNewswire
Technavio has announced its latest market research report titled Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2022-2026
This report offers an up-to-date analysis regarding the latest trends and drivers, the current market scenario, and the overall market environment.
Read FREE PDF Sample Report
Age-related Macular Degeneration Therapeutics Market 2022-2026: Segmentation
Type
Wet AMD: The
wet AMDAMD segment will be the largest contributor to market growth during the forecast period. Factors such as the rising use of vascular endothelial growth factor (VEGF) inhibitorsvascular endothelial growth factor (VEGF) inhibitors, which are largely used for the treatment of wet AMDAMD, are driving the growth of the segment.
Dry AMD
Geography
North America: North America will account for 42% of the market's growth during the forecast period. The growth of the market is attributed to factors such as the high prevalence of AMDAMD. Moreover, the growth of the market in this region is expected to be faster than the growth of the market in Europe. The US and Canada are the key countries for the age-related macular degeneration (AMD) therapeutics market in North America.
Europe
Asia
Rest Of World (ROW)
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
Age-related Macular Degeneration Market 2022-2026: Vendor Analysis and Scope
To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. Market vendors must strengthen their foothold in the fast-growing segments to leverage the current opportunities while maintaining their positions in the slow-growing segments.
The report also covers the following areas
:
Age-related Macular Degeneration Market industry analysis
Get lifetime access to our Technavio Insights. Subscribe now to our most popular
"Basic Plan" billed annually at USD 5000
. View 100 reports and download 5 reports monthly!
Age-related Macular Degeneration Market 2022-2026: Key Highlights
CAGR of the market during the forecast period
Detailed information on factors that will assist age-related macular degeneration market growth during the next five years
Estimation of the size of the age-related macular degeneration market and its contribution to the parent market
Forecasts on upcoming trends and changes in consumer behavior
The growth of the age-related macular degeneration market
Analysis of the competitive landscape of the market and detailed information on vendors
Comprehensive details of factors that will impede the growth of age-related macular degeneration market vendors
Related Reports
Open-Angle Glaucoma Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026: The open-angle glaucoma therapeutics market share is expected to increase by USD 2.58 billion from 2021 to 2026.
Myopia and Presbyopia Treatment Market by Type and Geography - Forecast and Analysis 2022-2026: Myopia and presbyopia treatment market share is expected to increase by USD 7.22 billion from 2021 to 2026.
Browse Health Care Market Reports
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Wet AMD - Market size and forecast 2021-2026
Exhibit 28: Chart on Wet AMDAMD - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Wet AMDAMD - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Wet AMDAMD - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Wet AMDAMD - Year-over-year growth 2021-2026 (%)
5.4 Dry AMD - Market size and forecast 2021-2026
Exhibit 32: Chart on Dry AMDAMD - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Dry AMD - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Dry AMDAMD - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Dry AMDAMD - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
Exhibit 85: Alkeus Pharmaceuticals Inc. - Overview
Exhibit 86: Alkeus Pharmaceuticals Inc. - Product / Service
Exhibit 87: Alkeus Pharmaceuticals Inc. - Key offerings
Exhibit 88: Allegro Ophthalmics LLC - Overview
Exhibit 89: Allegro Ophthalmics LLC - Product / Service
Exhibit 90: Allegro Ophthalmics LLC - Key offerings
Exhibit 91: Amgen Inc. - Overview
Exhibit 92: Amgen Inc. - Product / Service
Exhibit 93: Amgen Inc. - Key offerings
Exhibit 94: Apellis Pharmaceuticals Inc. - Overview
Exhibit 95: Apellis Pharmaceuticals Inc. - Product / Service
Exhibit 96: Apellis Pharmaceuticals Inc. - Key offerings
Exhibit 97: Bayer AG - Overview
Exhibit 98: Bayer AG - Business segments
Exhibit 99: Bayer AG - Key offerings
Exhibit 100: Bayer AG - Segment focus
Exhibit 101: F. Hoffmann La Roche Ltd. - Overview
Exhibit 102: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 103: F. Hoffmann La Roche Ltd. - Key news
Exhibit 104: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 105: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 106: Formycon AG - Overview
Exhibit 107: Formycon AG - Key offerings
Exhibit 108: Novartis AG - Overview
Exhibit 109: Novartis AG - Business segments
Exhibit 110: Novartis AG - Key offerings
Exhibit 111: Novartis AG - Segment focus
Exhibit 112: Outlook Therapeutics Inc. - Overview
Exhibit 113: Outlook Therapeutics Inc. - Product / Service
Exhibit 114: Outlook Therapeutics Inc. - Key offerings
Exhibit 115: Reliance Industries Ltd. - Overview
Exhibit 116: Reliance Industries Ltd. - Business segments
Exhibit 117: Reliance Industries Ltd. - Key offerings
Exhibit 118: Reliance Industries Ltd. - Segment focus
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 119: Inclusions checklist
Exhibit 120: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 121: Currency conversion rates for US$
11.4 Research methodology
Exhibit 122: Research methodology
Exhibit 123: Validation techniques employed for market sizing
Exhibit 124: Information sources
11.5 List of abbreviations
Exhibit 125: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.